Optimizing Cold Chain Management for Temperature-Sensitive Pharmaceuticals

By Nick Fryer, Vice President of Marketing at Sheer Logistics.

Prior to the COVID-19 pandemic, the temperature-controlled pharmaceutical supply chain was a somewhat niche industry. However, the urgent need for temperature-controlled storage and transportation of the COVID-19 vaccines accelerated the development of the pharmaceutical cold chain. At the same time, demand for temperature-sensitive pharmaceuticals such as biologics, mRNA, and personalized cell and gene therapies has increased significantly in the past five years.

While the pharma cold chain has evolved by leaps and bounds, challenges remain. Addressing these challenges and further optimizing the pharma cold chain requires collaboration between all the relevant stakeholders, including pharmaceutical companies, cold chain warehouses and distributors, and logistics service providers.

Overcoming Temperature Control Challenges in Global Distribution

Temperature control for pharmaceuticals is high stakes. Many healthcare products are shipped at refrigerated (between 34°F-50°F or 1°C-10°C) and frozen temperature ranges (0°F to -22°F or -18°C to -30°C). In addition, some pharmaceutical products, biological samples, and genetic materials for research are shipped at cryogenic temperatures, typically below -238°F (-150°C). If the cold chain fails, it doesn’t just cost companies money; it can lead to adverse health outcomes.

Here are a few other challenges for the pharmaceutical supply chain:

• The diversity of global climates when shipping across continents. Temperature and humidity changes can make maintaining a consistent, controlled environment that much more challenging.
• The risk of multimodal transport and the potential breakdowns in the cold chain it can cause. This is even more challenging in emerging markets where the infrastructure might not be as developed.
• Supply chain delays and errors that aren’t caught early enough and thus result in spoiled or expired pharmaceuticals. Broken packaging, poor packing strategies, and simply not tracking things properly all add to the risk.

There are many strategies that companies can take to overcome the above, including

• More advanced packaging solutions that can maintain low temperatures for days at a time.
• Investing in local cold storage infrastructure in outlying areas and more mobile solutions like solar-powered units.
• Better training on how to distribute loads, manage packaging carefully, etc.
• Real-time monitoring is perhaps the most important and effective way to optimize the pharmaceutical cold chain. As we’ll explore more in the next section, it can create real-time visibility that makes managing issues like temperature fluctuations that much easier.

Harnessing Real-Time Monitoring and IoT for Enhanced Supply Chain Visibility
More products equal more temperature sensitivity and greater complexity. IoT technology is one of the most effective tools for addressing these challenges.

IoT sensors can be used to track the “vital signs” of pharmaceutical products in real-time, including temperature, humidity levels, shock, and GPS location. Tracking all of this enhances supply chain visibility and, thanks to automated alerts, makes it far easier to catch problems early. No change goes unnoticed with IoT. Even a small increase in temperature, for example, can be flagged, which allows far more proactive and effective intervention.

Real-time monitoring of vehicles as well as products can also be used to inform Transportation Management Systems (TMS) so that routing and scheduling decisions can be further optimized. This helps ensure that the product isn’t sitting on trucks any longer than is absolutely necessary. IoT sensors can also be used to track if refrigeration units or vehicles are malfunctioning, which can help prevent breakdowns in the cold chain.

Strategic Approaches to Future-Proofing Cold Chain Infrastructure

Over time, the data collected by IoT sensors and other real-time tracking technology can build up a wealth of information on how best to future-proof the cold chain. AI-powered predictive analytics can use that data to build forecasts that highlight early warning signs of typical cold chain breakdowns, weather patterns that need to be accounted for, better shipping routes, and more.

This data can also point to areas that require strategic intervention, such as network design or partnering with a 4PL for greater supply chain control.

In today’s increasingly complex pharmaceutical landscape, the cold chain is no longer a niche concern - it’s a mission-critical component of global healthcare. As the demand for temperature-sensitive medicines continues to rise, optimizing cold chain management is essential for safeguarding product integrity and patient outcomes. By investing in real-time monitoring technologies, enhancing infrastructure, and fostering deeper collaboration across the supply chain, pharmaceutical companies and their partners can build a more resilient, agile, and future-ready cold chain.

Author Bio:

Nick Fryer has over a decade of experience in the logistics industry, spanning marketing, public relations, sales enablement, M&A, and more at 3PLs and 4PLs, including AFN Logistics, GlobalTranz, and Sheer Logistics.